Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells

Chinese Medical Journal

Volumn 121, Issue 22, 2008, Pages 2324-2330

  Zhang, Guang Mei ^a   Zhang, Ying Mei ^a   Fu, Song Bin ^a   Liu, Xing Han ^a   Fu, Xue ^a   Yu, Yan ^a   Zhang, Zhi Yi ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Angiogenesis inhibitors; Anti angiogenesis; Ovarian neoplasms; Tumstatin

Indexed keywords

ANGIOGENESIS INHIBITOR; PEPTIDE 21; TUMSTATIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; DRUG DESIGN; DRUG SYNTHESIS; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR CLONING; NONHUMAN; NUDE MOUSE; OVARY CANCER; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; TRANSMISSION ELECTRON MICROSCOPY; TUMOR VOLUME;

EID: 62749184885     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200811020-00020     Document Type: Article

References (17)

1. Maeshima Y, Colorado PC, Torre A, Holthaus KA, Grunkemeyer JA, Ericksen MB, et al. Distinct antitumor properties of a type IV collagen domain derived from basement membrane. J Biol Chem 2000; 275: 21340-21348.
2. Hamano Y, Kalluri R. Tumstatin, the NC1 domain of alpha3 chain of type IV collagen, is an endogenous inhibitor of pathological angiogenesis and suppresses tumor growth. Biochem Biophys Res Commun 2005; 333: 292-298.
3. Yu Q, Zhou LY, Lin XS, Xu JY, Wang SJ, Liu XH. Expression, purification and activity of recombinant human osteogenic growth peptide (rbOGP). Chin J Biochem Mol Bid (Chin) 2004; 20: 467-472.
4. Fu X, Wang SJ, Lin XS, Liu XH. Study on expression and biological activity of anti-angiogenic peptide of tumstatin. Chin J Med Mol Biol (Chin) 2005; 2: 157-161.
5. Pandya NM, Dhalla NS, Santani DD. Angiogenesis-a new target for future therapy. Vascul Pharmacol 2006; 44: 265-274.
6. Folkman J, Browder T, Palmblad J. Angiogenesis research: guidelines for translation to clinical application. Thromb Haemost 2001; 86: 23-33.
7. Morbidelli L, Donnini S, Chillemi F, Giachetti A, Ziche M. Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin. Clin Cancer Res 2003; 9: 5358-5369.
8. Kamphaus GD, Colorado PC, Panka DJ, Hopfer H, Ramchandran R, Torre A, et al. Canstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth. J Biol Chem 2000; 275: 1209-1215.
9. Maeshima Y, Manfredi M, Reimer C, Holthaus KA, Hopfer H, Chandamuri BR, et al. Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin. J Biol Chem 2001; 276: 15240-15248.
10. Colorado PC, Torre A, Kamphaus G, Maeshima Y, Hopfer H, Takahashi K, et al. Anti-angiogenic cues from vascular basement membrane collagen. Cancer Res 2000; 60: 2520-2526.
11. Sulochana KN, Ge R. Developing antiangiogenic peptide drugs for angiogenesis-related diseases. Curr Pharm Des 2007; 13: 2074-2086.
12. Maeshima Y, Manfredi M, Reimer C, Holthaus KA, Hopfer H, Chandamuri BR, et al. Identification of the anti-angiogenic site within vascular basement membrane-derived tumstatin. J Biol Chem 2001; 276: 15240-15248.
13. Pasco S, Ramont L, Maquart FX, Monboisse JC. Biological effects of collagen I and IV peptides. J Soc Biol 2003; 197: 31-39.
14. Floquet N, Pasco S, Ramont L, Derreumaux P, Laronze JY, Nuzillard JM, et al. The antitumor properties of the alpha3(IV)-(185-203) peptide from the NC1 domain of type IV collagen (tumstatin) are conformation-dependent. J Biol Chem 2004; 279: 2091-2100.
15. Mooney A, Jackson K, Bacon R, Streuli C, Edwards G, Bassuk J, et al. Type IV collagen and laminin regulate glomerular mesangial cell susceptibility to apoptosis via beta(1) integrin-mediated survival signals. Am J Pathol 1999; 155: 599-606.
16. Petitclerc E, Boutaud A, Prestayko A, Xu J, Sado Y, Ninomiya Y, et al. New functions for non-collagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo. J Biol Chem 2000; 275: 8051-8061.
17. Sato Y, Abe M, Tanaka K, Iwasaka C, Oda N, Kanno S, et al. Signal transduction and transcriptional regulation of angiogenesis. Adv Exp Med Biol 2000; 476: 109-115.